[{"data":1,"prerenderedAt":46},["ShallowReactive",2],{"q-nurse-110-1-medical-surgical-002":3},{"subject":4,"subjectSlug":5,"subjectFullName":4,"question":6,"related":22},"內外科護理學","medical-surgical",{"id":7,"webId":8,"year":9,"session":10,"subject":4,"number":11,"stem":12,"options":13,"answer":18,"answerNote":19,"images":20,"explanation":21,"freq":10},"nurse-110-1-內外科護理學-002","nurse-110-1-medical-surgical-002",110,1,2,"多發性硬化症（multiple sclerosis; MS）使用 Cyclophosphamide 藥物治療之最主要目的，下列何者正確？",{"A":14,"B":15,"C":16,"D":17},"抑制中樞神經","抑制免疫反應","抑制頻尿反應","抑制炎症反應","B",null,[],"本題考點為多發性硬化症(MS)使用 Cyclophosphamide 的治療目的。依藥理分類,Cyclophosphamide 是烷化劑類免疫抑制劑,MS 為 T 細胞攻擊中樞髓鞘的自體免疫疾病,用此藥最主要目的是抑制過度免疫反應,故選 B。選項 A 抑制中樞神經並非其機轉,它作用在免疫細胞 DNA 複製而非鎮靜中樞;選項 C 抑制頻尿屬對症治療,與此藥無關,膀胱症狀另有抗膽鹼藥處理;選項 D 抑制炎症雖與免疫調節部分重疊,但那是類固醇急性期消炎的角色,本藥核心定位是免疫抑制而非單純抗發炎。",[23,27,30,34,38,42],{"webId":24,"stem":25,"number":10,"year":26,"session":10},"nurse-106-1-medical-surgical-001","有關巴金森氏病治療之敘述，下列何者正確？",106,{"webId":28,"stem":29,"number":11,"year":26,"session":10},"nurse-106-1-medical-surgical-002","有關巴金森氏病的護理指導，下列何者正確？",{"webId":31,"stem":32,"number":33,"year":26,"session":10},"nurse-106-1-medical-surgical-003","下列何者為出血性腦中風最主要的危險因子？",3,{"webId":35,"stem":36,"number":37,"year":26,"session":10},"nurse-106-1-medical-surgical-004","有關頸部脊髓損傷的神經性休克徵象，下列何者正確？",4,{"webId":39,"stem":40,"number":41,"year":26,"session":10},"nurse-106-1-medical-surgical-005","陳小姐診斷為腦下垂體腫瘤，進行經蝶骨腦下垂體切除術，術後出現尿崩症，下列敘述何者錯誤？",5,{"webId":43,"stem":44,"number":45,"year":26,"session":10},"nurse-106-1-medical-surgical-006","顱底骨折常出現的徵象，下列何者錯誤？",6,1783840761995]